Furthermore, B-cell depletion therapy and protective therapeutic vaccination (combination) therapy led to a reduction in numbers of the CD19-B220+CD5+CD1d- Breg subset as well as in the expression of IL-10 on these cells and improved survival in mice harboring HCC. This evidence concerns the gene PTPRC and hepatocellular carcinoma.